Novartis Pharma AG

FDA-inspected organization

Novartis Pharma AG has been audited by the FDA 31 times between 2000 and 2024 across all 6 sites.


Documents

FDA 483 Novartis Pharma AG, Basel | 2022

483Aug 30, 2022Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2019

483Aug 29, 2019Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2017

483Jul 6, 2017Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2012

483Jul 26, 2012Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2009

483May 8, 2009Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2008

483Nov 21, 2008Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2008

483Jul 11, 2008Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2005

483Sep 30, 2005Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2005

483Jun 2, 2005Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2005

483Jun 2, 2005Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2003

483Mar 24, 2003Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2001

483May 10, 2001Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2001

483May 8, 2001Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2000

483Oct 30, 2000Basel / Switzerland
Out of stock

FDA 483 Novartis Pharma AG, Basel | 2000

483Oct 19, 2000Basel / Switzerland
Out of stock